Kate Morgan
Kate Morgan publishes mostly in Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Hematology, on topics such as Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Management and Research and Multiple Myeloma Research and Treatments.
- World rank
- #4,557,580 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #281,699 of 367,258
- Works
- 128
- Citations
- 666
- Citations per work
- 5.2
What does Kate Morgan research?
Kate Morgan's work is mostly in Medicine (44%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6348.9%
- Health Sciences5644.0%
- Medicine5644.0%
- Social Sciences97.1%
- 1Endocrinology, Diabetes and Metabolism23% of their works
- 2Economics and Econometrics7% of their works
- 3Hematology6% of their works
- 4Oncology6% of their works
- 5Epidemiology5% of their works
- 6Surgery4% of their works
Research topics
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Research
- Multiple Myeloma Research and Treatments
- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Neuroblastoma Research and Treatments
- Neuroendocrine Tumor Research Advances
- CAR-T cell therapy research
Which keywords describe Kate Morgan's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Critical Care, Hyperglycemia, Staging System, Diabetes, Hypoglycemia and Diagnosis Criteria.
- Neuroendocrine Tumors
- CAR T Cells
- ALK
- Quality of Life
- Cardiovascular Outcomes
- Genetic Mutations
- Diagnosis Criteria
- Diabetes
- Hyperglycemia
- Insulin Therapy
- Glycemic Control
- Critical Care
- Staging System
- Hypoglycemia
- International Myeloma Working Group
- Immunotherapy
- Cost-effectiveness Analysis
- Type 2 Diabetes
- Neuroblastoma
- Chimeric Antigen Receptor
- Pancreatic Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control763 topics
- Insulin Therapy763 topics
- Critical Care471 topic
- Hyperglycemia471 topic
- Staging System242 topics
- Diabetes201 topic
- Hypoglycemia201 topic
- Diagnosis Criteria161 topic
- International Myeloma Working Group161 topic
- Genetic Mutations152 topics
- Immunotherapy152 topics
- Cardiovascular Outcomes91 topic
- Cost-effectiveness Analysis91 topic
- Quality of Life91 topic
- Type 2 Diabetes91 topic
- ALK81 topic
- Neuroblastoma81 topic
- CAR T Cells71 topic
- Chimeric Antigen Receptor71 topic
- Neuroendocrine Tumors71 topic
- Pancreatic Neuroendocrine Tumors71 topic
Where does Kate Morgan work?
Kate Morgan's main affiliation in the publication record is University College London, United Kingdom.
How many publications and citations does Kate Morgan have?
OpenAlex counts 128 works and 666 citations for Kate Morgan, an h-index of 14, ranking #4,557,580 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Kate Morgan
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kate Morgan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.